Event : Challenges that must be Considered When First-in-Human and Subsequent Phase I studies are Contemplated - Webinar By GlobalCompliancePanel http://www.rsc.org/events/detail/7090/Challenges%20that%20must%20be%20Considered%20When%20First-in-Human%20and%20Subsequent%20Phase%20I%20studies%20are%20Contemplated%20-%20Webinar%20By%20GlobalCompliancePanel This is a feed for event : Challenges that must be Considered When First-in-Human and Subsequent Phase I studies are Contemplated - Webinar By GlobalCompliancePanel Thu, 11 Sep 2014 13:13:13 +0100 7090 7090 http://www.rsc.org/events/detail/7090/Challenges%20that%20must%20be%20Considered%20When%20First-in-Human%20and%20Subsequent%20Phase%20I%20studies%20are%20Contemplated%20-%20Webinar%20By%20GlobalCompliancePanel Challenges that must be Considered When First-in-Human and Subsequent Phase I studies are Contemplated - Webinar By GlobalCompliancePanel Event dates: 6 March 2012<br/>Event summary: This Webinar goes over the scientific standards of the First-in-Human ("first-in-Man" / FIM) studies and other Phase I studies in the drug development process. The FiM and other Phase I studies set <br/>Event Venue: OnlineTraining, Wilmington, 19801, United States Thu, 11 Sep 2014 13:13:13 +0100 2014-09-11T13:13:13+01:00